Aim: As capsular perforation is still regarded as one of complications of transurethral prostatectomy, the aim of this study was to compare the properties in penetrating capsular tissue of transurethral plasmakinetic resection (PKRP) and transurethral resection of the prostate (TURP). Methods: Isolated normal saline-perfused porcine kidneys were used to determine the penetrating capsule properties of PKRP and TURP. We quantified and compared the time of cutting through renal surface during different procedures. Results: The time of perforating renal capsula induced by PKRP was longer than that by TURP (p < 0.05). As soon as the operator activated footswitch, the renal capsula was cut through by the monopolar loop. The duration was always less than 1 s in the TURP group, although sometimes the plasma-loop could not penetrate the velamen (15/40). The time of penetrating the renal surface with capsula induced by PKRP was longer than that without capsula (p < 0.05). The duration of penetrating the surface without capsula was always less than 1 s. Conclusions: With the present ex vivo model, we provided evidence that it is more difficult to penetrate capsular tissue with PKRP compared to TURP.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.